Xcout Intel
EnGraft Technologies, Inc.
EnGraft Technologies develops medical devices for hair restoration, specifically offering the patented Duplex Implanter to improve the speed, consistency, and efficiency of hair transplant procedures. The company serves accredited surgeons by providing tools designed to enhance hair transplant outcomes at a lower cost.
Subscribe to see EnGraft Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EnGraft Technologies, Inc. at a glance
EnGraft Technologies, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $1M in May 2023. Xcout tracks 3 named people at EnGraft Technologies, Inc., including Jennifer Lee (President and CEO).
EnGraft Technologies, Inc. leadership
- Jennifer LeePresident and CEO
- Pascal BoudjemaCo-Founder
- William RassmanCo-Founder
EnGraft Technologies, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
EnGraft Technologies, Inc. competitors
A few of EnGraft Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Hairstetics is an Israeli medical-device company developing minimally invasive treatments for hair loss. Its technology is designed to implant synthetic hair fibers using a dedicated implantation device, serving people seeking hair restoration, including those with androgenetic alopecia.
BioSculpture Technology, Inc. develops and manufactures medical devices and surgical instruments, specializing in advanced power-assisted dual-cannula tissue aspiration systems. The company serves physicians in the liposuction, body sculpting, bariatric treatment, and fat autograft and stem cell processing markets.
Kogent Surgical, LLC manufactures specialized medical devices and microsurgical instrumentation, including disposable and reusable bipolar forceps, illuminated suctions, and titanium instruments. The company serves microsurgeons globally by providing advanced electrosurgery and surgical site illumination products.
BiPad, Inc. designs and manufactures FDA-approved, hand-activated bipolar forceps that eliminate the need for traditional foot pedals during surgical procedures. The company's products are aimed at hospitals, surgeons, and operating room staff to reduce the risk of surgical site infections, improve workflow efficiency, and enhance surgical precision.
RheoTek Medical LLC is developing an injection technology platform for applications in face and hair aesthetics, medical dermatology, and skin cancer. The company's technology is under clinical evaluation to provide precise injection depths, optimal dispersion, and reduced pain while supporting reproducible outcomes for existing and novel therapeutics.
DuraStat LLC develops and provides a specialized surgical device designed to facilitate faster and higher-quality dural repairs during spine surgery. The product aims to help clinicians and hospitals prevent persistent cerebrospinal fluid leaks by automating suture passage and improving access in restricted surgical environments.
Get EnGraft Technologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on EnGraft Technologies, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access